Understanding the Limitations of Cuff-Based Blood Pressure Measurements and How Improvements Can Enhance Accuracy

New research explains why cuff-based blood pressure readings can be inaccurate and suggests simple protocol modifications to improve measurement precision, potentially reducing missed hypertension diagnoses.
High blood pressure, or hypertension, remains the leading risk factor for premature death worldwide, contributing significantly to heart disease, strokes, and heart attacks. Despite the widespread use of cuff-based blood pressure measurements in clinical practice, research indicates that these readings can often be inaccurate, potentially missing up to 30% of hypertension cases.
A recent study by researchers at the University of Cambridge has shed light on the physics behind these inaccuracies. Traditional cuff-based methods, known as auscultatory measurements, involve inflating a cuff around the upper arm to stop blood flow temporarily, then slowly deflating it while listening for specific sounds through a stethoscope. Blood pressure readings are derived from the pressure gauges attached to the cuff, providing two numbers: systolic (maximum pressure) and diastolic (minimum pressure). The ideal blood pressure level is considered to be around 120/80 mmHg.
However, clinicians and researchers have long noted that this method tends to overestimate diastolic pressure and underestimate systolic pressure. While the overestimation of diastolic pressure has been well understood, the reason for systolic underestimation remained unclear.
Through their experiments, the Cambridge team constructed a physical model simulating arteries and blood flow. They discovered that when the cuff inflates and blood flow is stopped, the downstream pressure below the cuff becomes very low. This low downstream pressure causes the artery to stay closed longer while the cuff deflates, delaying its reopening. This delay results in an underestimation of the true systolic blood pressure, a phenomenon caused by a physical mechanism previously not fully recognized.
The study suggests that many inaccuracies in blood pressure readings are due to this effect, leading to the potential underdiagnosis of hypertension. Importantly, their findings show that simple changes in measurement protocols could significantly improve accuracy. For example, elevating the arm before measurement could alter downstream pressure and reduce underestimation, without the need for new devices.
Moreover, future blood pressure monitoring technologies could incorporate additional parameters such as age, BMI, or tissue characteristics to better account for individual differences and improve measurement precision. The researchers plan to conduct clinical trials to validate these findings and work with industry and medical professionals to refine measurement protocols.
In summary, understanding and addressing the physical dynamics affecting cuff-based blood pressure readings can lead to more accurate diagnoses and better health outcomes for patients. Small protocol adjustments could drastically reduce the number of missed hypertension cases, ultimately saving lives.
Source: https://medicalxpress.com/news/2025-08-common-cuff-based-blood-pressure.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Off-the-Shelf Immunotherapy Shows Promise for Metastatic Kidney Cancer
UCLA researchers have developed a revolutionary off-the-shelf immunotherapy using engineered immune cells to target and treat metastatic kidney cancer, offering hope for more effective and accessible treatments.
Updated Clinical Guidelines on Pharmacotherapy for Obesity Management
New guidelines for obesity pharmacotherapy highlight personalized treatment options, including new medications, and emphasize obesity as a chronic disease requiring long-term management strategies.
Molgramostim Shows Promise in Treating Autoimmune Pulmonary Alveolar Proteinosis
Inhaled molgramostim demonstrates significant improvements in lung function for adults with autoimmune pulmonary alveolar proteinosis, offering new hope for treatment. Read the latest research findings.
Breakthrough Monoclonal Antibody Offers New Hope in Sepsis Treatment
A novel monoclonal antibody developed by scientists at UVA and Michigan shows promise in preventing sepsis by stopping cytokine storms, with potential for broader inflammatory disease treatment.